Načítá se...
Current status of treatment of cancer-associated venous thromboembolism
Patients with cancer are prone to develop venous thromboembolism (VTE) that is the second leading cause of mortality among them. Cancer patients with VTE may encounter higher rates of VTE recurrence and bleeding complications than patients without cancer. Treatment of established VTE is often comple...
Uloženo v:
| Vydáno v: | Thromb J |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8010277/ https://ncbi.nlm.nih.gov/pubmed/33789658 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12959-021-00274-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|